FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

20419511000001103: Oteracil potassium (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68825101000001116 Oteracil potassium (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68825201000001111 Oteracil potassium en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oteracil potassium Is a Substance with transferase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Generic Teysuno 15mg/4.35mg/11.8mg capsules Has specific active ingredient True Oteracil potassium Inferred relationship Existential restriction modifier
Generic Teysuno 20mg/5.8mg/15.8mg capsules Has specific active ingredient True Oteracil potassium Inferred relationship Existential restriction modifier
Teysuno 20mg/5.8mg/15.8mg capsules (Nordic Pharma Ltd) Has specific active ingredient True Oteracil potassium Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) Has specific active ingredient True Oteracil potassium Inferred relationship Existential restriction modifier
Generic Teysuno 15mg/4.35mg/11.8mg capsules 126 capsule Has specific active ingredient True Oteracil potassium Inferred relationship Existential restriction modifier
Generic Teysuno 20mg/5.8mg/15.8mg capsules 84 capsule Has specific active ingredient True Oteracil potassium Inferred relationship Existential restriction modifier
Teysuno 20mg/5.8mg/15.8mg capsules (Nordic Pharma Ltd) 84 capsule 6 x 14 capsules Has specific active ingredient True Oteracil potassium Inferred relationship Existential restriction modifier
Teysuno 15mg/4.35mg/11.8mg capsules (Nordic Pharma Ltd) 126 capsule 9 x 14 capsules Has specific active ingredient True Oteracil potassium Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start